Leads Biolabs
Nanjing
About Leads Biolabs
Leads Biolabs is a biotechnology company that develops treatment outcomes and access for patients worldwide. The company is committed to researching and developing novel antibody-based therapeutics in oncology and immunological disease areas in order to meet patients' global unmet needs. On the monoclonal antibody and bispecific antibody development technology platform, they already have a robust research and development pipeline with over ten innovative cancer immunotherapy antibody projects. Leads Biolabs was founded in 2014 and is headquartered in China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $100.1M
- Funding stage: IPO
- Last round: Series C (Oct 2021)
- Ticker: hkg:9887
- Website: leadsbiolabs.com
- Phone: 025-83378099
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/leads-biolabs-1925 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.